The primary composite outcome of major adverse cardiac events plus (MACE+), including death from CV causes, nonfatal MI, and hospitalization for unstable angina, was reached in 13.4% of patients in the lixisenatide group and 13.2% of patients in placebo group, demonstrating noninferiority, but not superiority, of lixisenatide compared with placebo
Carrington R, Staffurth J, Warren S, Partridge M, Hurt C, Spezi E, et al
In: Atlas of Geriatric Dermatology
Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats
Clin Endocrinol (Oxf) (2011) 75(4):5616.10.1111/j.1365-2265.2011.04075.x 96 HaringRFriedrichNVlzkeHVasanRSFelixSBDrrMet alPositive association of serum prolactin concentrations with all-cause and cardiovascular mortality
CLINICALLY VALIDATED FORMULA Includes Eriomin Lemon Flavonoids, Berberine, Beta Glucan, Cinnamon & more